Catalyst Wire Dossier Catalyst Wire Dossier

JTK-853

· Akros Pharma Inc.
Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for JTK-853, covering 2011-11-21 to 2011-11-22. Get the full timeline:

Most recent: Clinical Trial Update: Safety, Tolerability and Pharmacokinetics Study Assessing Ascending Single Oral JTK-853 Doses in Healthy Subjects [Phase 1]

See pricing